Monplast LC Syrup is a combination of Levocetirizine (2.5mg) and Montelukast (4mg), designed to effectively manage respiratory allergies and asthma symptoms, especially in children. This dual-action formulation targets both the histamine response and inflammatory pathways to provide fast and long-lasting relief from allergic rhinitis, sneezing, nasal congestion, runny nose, watery eyes, and mild asthma.
Levocetirizine, a third-generation non-sedating antihistamine, blocks the action of histamine—a natural substance produced during allergic reactions. It provides rapid relief from itching, nasal stuffiness, and skin manifestations of allergies with minimal drowsiness, making it suitable for pediatric use.
Montelukast, a leukotriene receptor antagonist, works by blocking leukotrienes, which are inflammatory mediators involved in allergic responses and asthma. It helps to reduce airway inflammation, wheezing, and bronchoconstriction, making breathing easier and improving overall respiratory function. Montelukast is particularly beneficial in preventing nighttime asthma attacks and symptoms triggered by allergens like pollen, dust, or pet dander.
Together, these two active ingredients provide synergistic relief by reducing inflammation, bronchospasm, and allergic symptoms at their source. Monplast LC Syrup is ideal for children suffering from allergic rhinitis, seasonal allergic conditions, or asthma that is aggravated by environmental triggers.
The syrup is pleasantly flavored and easy to administer, ensuring compliance in pediatric patients. Regular use as prescribed can help improve breathing, reduce coughing fits, and minimize school absenteeism due to allergy or mild asthma.
Caregivers should be attentive to dosage schedules and inform their doctor about any unusual side effects or behavioral changes. As with any pediatric medication, Monplast LC should be used under medical supervision.